|
|
Joined: Dec 1999
Posts: 30,867
Master Elite Member
|
CDC Rescinds Authorization for PCR Test Because It Cannot Distinguish Between SARS-CoV-2 and the FluThe CDC quietly announced last week that it was withdrawing its request to the FDA for Emergency Use Authorization (EUA) of the 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2.
Most of the public is probably unaware that similar to the current COVID-19 injections that are not yet approved by the FDA, but only given Emergency Use Authorization, so too the hundreds of diagnostic tests that supposedly detect COVID-19 are also NOT approved by the FDA, but only authorized via an EUA.
What is the reason the CDC is withdrawing its EUA request for the Real-Time RT-PCR Diagnostic Panel?
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test.
CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses.
Story Medical KidnapSee Disease Rates of Vaccinated-Unvaccinated Children
See New Study: Diseases Declined Long Before Related Vaccines Implemented
See Chemtrails Contain MercuryReturn to the Vaccine ForumReturn to The Covid Forum![[Linked Image]](http://orbisvitae.com/ubbthreads/ubbthreads.php?ubb=download&Number=5148&filename=cdc-gov-csels-dls-locs-2021-07-21-2021-lab-alert-Changes-CDC-RT-PCR-SARS-CoV-2-Testing-1-html-narrow-2021-07-29-10_22_05.png) ![[Linked Image]](http://orbisvitae.com/ubbthreads/ubbthreads.php?ubb=download&Number=5147&filename=fda-gov-medical-devices-medical-device-recalls-innova-medical-group-recalls-unauthorized-sars-cov-2-antigen-rapid-qualitative-test-risk-false-test-2021-07-29-10_14_54.png)
Last edited by Russ; 07/29/21 10:33 AM.
|
|
|
|
|